BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31002702)

  • 21. Health and economic consequences of different options for timing the coordinated global cessation of the three oral poliovirus vaccine serotypes.
    Thompson KM; Duintjer Tebbens RJ
    BMC Infect Dis; 2015 Sep; 15():374. PubMed ID: 26381878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial.
    Heyderman RS; Madhi SA; French N; Cutland C; Ngwira B; Kayambo D; Mboizi R; Koen A; Jose L; Olugbosi M; Wittke F; Slobod K; Dull PM
    Lancet Infect Dis; 2016 May; 16(5):546-555. PubMed ID: 26869376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity of Two Different Sequential Schedules of Inactivated Polio Vaccine Followed by Oral Polio Vaccine Versus Oral Polio Vaccine Alone in Healthy Infants in China.
    Li RC; Li CG; Wang HB; Luo HM; Li YP; Wang JF; Ying ZF; Yu WZ; Shu JD; Wen N; Vidor E
    J Pediatric Infect Dis Soc; 2016 Sep; 5(3):287-96. PubMed ID: 26407255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
    Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
    J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of Oral Polio Vaccine and the Global Incidence of Mother-to-Child Human Immunodeficiency Virus Transmission.
    Habibzadeh F; Yadollahie M; Simi A
    Front Public Health; 2022; 10():878298. PubMed ID: 35812500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth patterns of infants with in- utero HIV and ARV exposure in Cape Town, South Africa and Lusaka, Zambia.
    Nyemba DC; Kalk E; Vinikoor MJ; Madlala HP; Mubiana-Mbewe M; Mzumara M; Moore CB; Slogrove AL; Boulle A; Davies MA; Myer L; Powis K
    BMC Public Health; 2022 Jan; 22(1):55. PubMed ID: 35000577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba.
    Cuba IPV Study Collaborative Group
    N Engl J Med; 2007 Apr; 356(15):1536-44. PubMed ID: 17429085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria.
    Giwa FJ; Olayinka AT; Ogunshola FT
    Vaccine; 2012 Nov; 30(48):6759-65. PubMed ID: 23000220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine.
    Brickley EB; Strauch CB; Wieland-Alter WF; Connor RI; Lin S; Weiner JA; Ackerman ME; Arita M; Oberste MS; Weldon WC; Sáez-Llorens X; Bandyopadhyay AS; Wright PF
    J Infect Dis; 2018 Jan; 217(3):371-380. PubMed ID: 29304199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initiation of Antiretroviral Therapy Before Pregnancy Reduces the Risk of Infection-related Hospitalization in Human Immunodeficiency Virus-exposed Uninfected Infants Born in a High-income Country.
    Goetghebuer T; Smolen KK; Adler C; Das J; McBride T; Smits G; Lecomte S; Haelterman E; Barlow P; Piedra PA; van der Klis F; Kollmann TR; Lauffenburger DA; Alter G; Levy J; Marchant A
    Clin Infect Dis; 2019 Mar; 68(7):1193-1203. PubMed ID: 30215689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the first 2 years of life.
    Reikie BA; Naidoo S; Ruck CE; Slogrove AL; de Beer C; la Grange H; Adams RC; Ho K; Smolen K; Speert DP; Cotton MF; Preiser W; Esser M; Kollmann TR
    Clin Vaccine Immunol; 2013 Jan; 20(1):33-8. PubMed ID: 23114697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunologic response to oral polio vaccine in human immunodeficiency virus-infected and uninfected Zimbabwean children.
    Gnanashanmugam D; Troy SB; Musingwini G; Huang C; Halpern MS; Stranix-Chibanda L; Shetty AK; Kouiavskaia D; Nathoo K; Chumakov K; Maldonado YA
    Pediatr Infect Dis J; 2012 Feb; 31(2):176-80. PubMed ID: 22146742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody response and viral excretion after live polio vaccine or a combined schedule of live and inactivated polio vaccines.
    Ramsay ME; Begg NT; Gandhi J; Brown D
    Pediatr Infect Dis J; 1994 Dec; 13(12):1117-21. PubMed ID: 7892081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial.
    Asturias EJ; Bandyopadhyay AS; Self S; Rivera L; Saez-Llorens X; Lopez E; Melgar M; Gaensbauer JT; Weldon WC; Oberste MS; Borate BR; Gast C; Clemens R; Orenstein W; O'Ryan G M; Jimeno J; Clemens SA; Ward J; Rüttimann R;
    Lancet; 2016 Jul; 388(10040):158-69. PubMed ID: 27212429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use.
    Duintjer Tebbens RJ; Hampton LM; Thompson KM
    BMC Infect Dis; 2016 Jun; 16():237. PubMed ID: 27246198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shedding of Oral Poliovirus Vaccine (OPV) by HIV-Infected and -Uninfected Mothers of OPV-Vaccinated Zimbabwean Infants.
    Holubar M; Troy SB; Nathoo K; Stranix-Chibanda L; Musingwini G; Srinivas N; Huang C; Junn A; Halpern MS; Maldonado YA
    J Pediatric Infect Dis Soc; 2017 Mar; 6(1):105-108. PubMed ID: 26759497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination with 10-valent pneumococcal conjugate vaccine in infants according to HIV status.
    Madhi SA; Koen A; Jose L; van Niekerk N; Adrian PV; Cutland C; François N; Ruiz-Guiñazú J; Yarzabal JP; Moreira M; Borys D; Schuerman L
    Medicine (Baltimore); 2017 Jan; 96(2):e5881. PubMed ID: 28079828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of diarrhea on the humoral response to oral polio vaccination.
    Myaux JA; Unicomb L; Besser RE; Modlin JF; Uzma A; Islam AM; Santosham M
    Pediatr Infect Dis J; 1996 Mar; 15(3):204-9. PubMed ID: 8852907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.
    Swartz TA; Green MS; Handscher R; Sofer D; Cohen-Dar M; Shohat T; Habib S; Barak E; Dror Z; Somekh E; Peled-Leviathan T; Yulzari R; Libling A; Mendelson E; Shulman LM
    Vaccine; 2008 Feb; 26(8):1083-90. PubMed ID: 18241962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early structural brain development in infants exposed to HIV and antiretroviral therapy in utero in a South African birth cohort.
    Wedderburn CJ; Groenewold NA; Roos A; Yeung S; Fouche JP; Rehman AM; Gibb DM; Narr KL; Zar HJ; Stein DJ; Donald KA
    J Int AIDS Soc; 2022 Jan; 25(1):e25863. PubMed ID: 35041774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.